期刊文献+

齐拉西酮对精神病人糖代谢的影响研究 被引量:5

下载PDF
导出
摘要 目的探讨齐拉西酮对精神病人糖代谢的影响。方法对40例服用齐拉西酮、60例服用氯氮平治疗的精神病人在治疗前、治疗第4、8、12周末及终末期测量空腹血糖或餐后2小时血糖,比较两组患者糖代谢异常及糖尿病发生率。结果氯氮平导致糖代谢异常或糖尿病较齐拉西酮发生率高,两组差异有极显著性(P<0.01)。结论齐拉西酮引起糖代谢异常及糖尿病发病较氯氮平轻,在监测血糖的情况下可安全应用。
出处 《中国现代医生》 2009年第8期91-92,共2页 China Modern Doctor
  • 相关文献

参考文献6

  • 1蒋国彦.现代糖尿病学[M].北京:人民卫生出版社,1998.957.
  • 2王健,翟书涛.精神分裂症与糖尿病[J].临床精神医学杂志,2002,12(5):297-298. 被引量:16
  • 3NsrallahHA.非典型抗精神病药物所致的代谢副作用:透视受体结合特点.精神相关疾病论坛,2008,1:14-21.
  • 4Roger S.Anfipsychtic metabolic effects:weight gain,diabetes mellitus and lipid abnormalities[J].Can J Psychiatry,2001,46:273-275.
  • 5肖春兰,周天骍,张少平,陈银娣,丛志军,彭伟君,刘仁申,薛玲妹,范幼珠.氯氮平与利培酮对精神病患者糖代谢影响的对照研究[J].上海精神医学,2002,14(4):201-203. 被引量:19
  • 6Henderson De.Clozapine,diabtes,diabtes etllitus,weight gain and lipid abnormalities:a five-year naturalistic study[J].Am J Psychiatry,2000,157:975-976.

二级参考文献15

  • 1蒋国彦.现代糖尿病学[M].北京:人民卫生出版社,1998.957.
  • 2Lindenmayer JP,Patel R.Olanzapine-induced ketoacidosis with diabetes mellitus.Am J Psychiatry,1999,156:1471
  • 3Wirshing DA,Spellberg BJ,Erhart SM,et al.Novel antipsychotics and newonset diabetes.Biol Psychiatry,1998,44:778
  • 4Schultz SK,Arndt S,Ho BC,et al.Impaired glucose tolerance and abnormal movements in patients with schizophrenia.Am J Psychiatry,1999,156: 640
  • 5John W,Newcomer SC,Robert F,et al.Glucose-induced increase in memory performance in patients with schizophrenia.Schizophrenia Bull,1999,25:321
  • 6Mukherjee S,Decina P,Bocola V,et al.Diabetes mellitus in schizophrenic patients.Compr Psychiatry,1996,37:68
  • 7Henderson DC, Cagliero E, Gray C,et al.Clozapine,diabetes mellitus,weight gain,and lipid abnormalities:a five-year naturalistic study.Am J Psychiatry,2000 157: 975
  • 8Hagg S, Joelsson L, Mjorndal T,et al.Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.J Clin Psychiatry,1998,59: 294
  • 9Mohan D,Gordon H,Hindley N,et al.Schizophrenia and diabetes mellitus.Br J Psychiatry,1999,174:180
  • 10Kowd MS, Rames LJ, et al. Diabetic ketoacidosis associated with clozapine reatment. Am J Psychiatry, 1994, 151 : 1520

共引文献34

同被引文献50

  • 1张桂华,赵祖安,丁琳.齐拉西酮致迟发性运动障碍1例[J].中国民康医学,2009,21(21):2703-2703. 被引量:4
  • 2戢秋明 谢良平.精神疾病与糖尿病共病分析[J].临床精神医学杂志,2000,10(5):272-272.
  • 3Simpson GM. Atypical anti psychotics and the burden of disease[J]. Am J Manag Care,2005,11:235- 241.
  • 4Stimmel GL,Gutierrez MA,Lee V.2iprasidone:an atypicalantipsychotic drug for the treatment of schizophrenia [J].ClinTher,2002,24(1):21-37.
  • 5Leibold J,Patel V,Hasan RA.Neuroleptic malignant syndromeassociated with ziprasidone in an adolescent[J] .Clin Ther,2004,26(7):1105-1108.
  • 6Tsai CS,Lee Y,Chang YY,et al.Ziprasidone-induced tardivelaryngeal dystonia:a case report [J].Gen Hosp Psychiatry,2008,30(3):277-279.
  • 7Yumru M,Savas HA,Selek S,et al.Acute dystonia after initial dosesof ziprasidone:a case report [J].Prog Neuropsychopharmacol BiolPsychiatry, 2006, 30(4):745-747.
  • 8Sachet J, Mossaheb N, Spindelegger C, et al. Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers[J]. Neuropsy- chopharmacology,2008,33: 1 633 - 1 641.
  • 9Brown RR, Estoup MW. Comparison of the metabolic effects observed in patients treated with ziprasidone versus olan[J]. International Clinical Psychopharmacology,2005,20(2): 105 - 112.
  • 10Rettenhaeherl MA, Ebenbichler C, Hofer A, et al. Alterations of glu- cose metabolism in patients treated with ziprasidone vsclozapine[J] . Schizophrenia Research, 2010,117 (2) : 506.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部